Windsor Capital Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$311K Hold
3,010
0.08% 105
2026
Q1
$216K Hold
3,010
0.06% 116
2025
Q4
$239K Hold
3,010
0.07% 110
2025
Q3
$227K Sell
3,010
-25
-0.8% -$1.71K 0.06% 115
2025
Q2
$209K Hold
3,035
0.06% 116
2025
Q1
$206K Buy
+3,035
New +$182K 0.06% 116
2018
Q1
Sell
-2,975
Closed -$215K 118
2017
Q4
$215K Buy
2,975
+4
+0.1% +$291 0.1% 106
2017
Q3
$239K Hold
2,971
0.12% 101
2017
Q2
$239K Buy
2,971
+2
+0.1% +$158 0.12% 103
2017
Q1
$233K Sell
2,969
-52
-2% -$4.15K 0.12% 103
2016
Q4
$238K Buy
3,021
+56
+2% +$4.53K 0.13% 101
2016
Q3
$263K Buy
2,965
+2
+0.1% +$189 0.14% 102
2016
Q2
$283K Buy
2,963
+1
+0% +$100 0.17% 97
2016
Q1
$307K Buy
2,962
+2
+0.1% +$194 0.19% 92
2015
Q4
$289K Buy
2,960
+1
+0% +$98 0.18% 92
2015
Q3
$285K Buy
+2,959
New +$311K 0.17% 92
2014
Q1
Sell
-953
Closed -$68K 118
2013
Q4
$68K Buy
953
+2
+0.2% +$129 0.04% 146
2013
Q3
$54K Buy
951
+1
+0.1% +$60 0.03% 167
2013
Q2
$54K Buy
+950
New +$55K 0.03% 158

Other funds holding CVS

Windsor Capital Management's CVS Position: Q2 2026 in Review

Windsor Capital Management held its CVS Health (CVS) position steady in Q2 2026 at 3,010 shares worth $311K. The position accounts for 0.08% of the portfolio, ranked #105.

Windsor Capital Management first reported a position in CVS in Q2 2013 and has held it in 19 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Windsor Capital Management held 3,010 shares of CVS Health worth $311K as of Q2 2026.
  • Windsor Capital Management left its CVS Health share count unchanged in Q2 2026.
  • CVS Health made up 0.08% of Windsor Capital Management's portfolio in Q2 2026, its #105 holding.
  • Windsor Capital Management first reported a position in CVS Health in Q2 2013 and has held it in 19 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Windsor Capital Management's 13F filing for Q2 2026, filed 8 Jul 2026.